Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis c
Symptom C0235378|hepatotoxicity
Sentences 3
PubMedID- 20818300 The available literature regarding the safety of statins in this patient population is limited, but has not shown clinically significant differences in aminotransferase elevations or evidence of hepatotoxicity in patients with hepatitis c who have received statins versus those who have not.
PubMedID- 23543311 It has been reported that treatment with hmg-coa reductase inhibitors does not increase the risk of severe hepatotoxicity in patients with chronic hepatitis c , which is consistent with our present results showing no adverse events associated with the addition of flv.
PubMedID- 20470823 Viral hepatitis co-infection was not associated with severe hepatotoxicity, mortality, severe morbidity or virological failure in multivariate analyses.

Page: 1